Dongcheng Pharmaceutical Group

Dongcheng Pharmaceutical Group is a prominent Chinese pharmaceutical company that has evolved from a leading biochemical API manufacturer into a comprehensive healthcare provider with a focus on nuclear medicine. Headquartered in Yantai, the company is one of the world's largest suppliers of heparin sodium and chondroitin sulfate, serving a global market for anticoagulant and joint health products. In recent years, Dongcheng has strategically pivoted toward the radiopharmaceutical sector, establishing a full industry chain that encompasses the R&D, production, and distribution of diagnostic and therapeutic radiopharmaceuticals. Through its extensive network of radiopharmacies across China, the company provides critical imaging agents for oncology and neurology, including advanced PET/CT tracers. Dongcheng is publicly traded on the Shenzhen Stock Exchange and continues to expand its footprint in precision medicine and high-end formulations.